Certolizumab pegol

Category: biologic

Aliases: Cimzia, PEGylated anti-TNFα Fab'

Pharmacological Mechanism

Humanised anti-TNFα Fab' fragment conjugated to a 40 kDa branched polyethylene glycol (PEG) moiety. Lacks the IgG Fc region → no complement activation, no antibody-dependent cytotoxicity, and importantly no FcRn-mediated transplacental transfer (preferred anti-TNF during pregnancy). PEGylation extends half-life and reduces immunogenicity compared to native Fab'.

Half-Life (t½)

SC: 336h

Dosing Guidelines

Target Organ Systems